DLG5 Gene (Discs Large Homolog 5)
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | DLG5 |
| Full Name | Discs Large Homolog 5 |
| Chromosomal Location | 10q22.3 |
| NCBI Gene ID | 9231 |
| OMIM | 604455 |
| Ensembl ID | ENSG00000154655 |
| UniProt | Q9NZU7 |
| Protein Name | Discs large homolog 5 |
| Associated Diseases | Parkinson's Disease, Alzheimer's Disease, Intellectual Disability, Autism, Inflammatory Bowel Disease |
</div>
Overview
DLG5 (Discs Large Homolog 5) encodes a member of the membrane-associated guanylate kinase (MAGUK) family of scaffolding proteins. MAGUK proteins are characterized by their ability to assemble multi-protein signaling complexes at the plasma membrane, organizing proteins into functional units that regulate cell polarity, signal transduction, and synaptic communication[@nakamura2002][@carreno2012].
DLG5 is a large protein of 1917 amino acids containing multiple functional domains, including PDZ (PSD-95/DLG/ZO-1) domains, an SH3 (Src homology 3) domain, and a GUK (guanylate kinase) domain. These domains enable DLG5 to interact with numerous partner proteins, positioning it at the intersection of multiple signaling pathways critical for neuronal function and survival[@siddiqui2013].
...
DLG5 Gene (Discs Large Homolog 5)
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | DLG5 |
| Full Name | Discs Large Homolog 5 |
| Chromosomal Location | 10q22.3 |
| NCBI Gene ID | 9231 |
| OMIM | 604455 |
| Ensembl ID | ENSG00000154655 |
| UniProt | Q9NZU7 |
| Protein Name | Discs large homolog 5 |
| Associated Diseases | Parkinson's Disease, Alzheimer's Disease, Intellectual Disability, Autism, Inflammatory Bowel Disease |
</div>
Overview
DLG5 (Discs Large Homolog 5) encodes a member of the membrane-associated guanylate kinase (MAGUK) family of scaffolding proteins. MAGUK proteins are characterized by their ability to assemble multi-protein signaling complexes at the plasma membrane, organizing proteins into functional units that regulate cell polarity, signal transduction, and synaptic communication[@nakamura2002][@carreno2012].
DLG5 is a large protein of 1917 amino acids containing multiple functional domains, including PDZ (PSD-95/DLG/ZO-1) domains, an SH3 (Src homology 3) domain, and a GUK (guanylate kinase) domain. These domains enable DLG5 to interact with numerous partner proteins, positioning it at the intersection of multiple signaling pathways critical for neuronal function and survival[@siddiqui2013].
In the central nervous system, DLG5 plays essential roles in maintaining neuronal polarity, organizing synaptic structures, and coordinating signaling cascades that regulate synaptic plasticity, learning, and memory. DLG5 has been genetically associated with [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), and various neurodevelopmental disorders including intellectual disability and [autism spectrum disorder](/diseases/autism)[@friedman2009][@yoshikawa2017][@riviere2012].
Molecular Biology
Gene Structure
The human DLG5 gene spans approximately 40 kb on chromosome 10q22.3 and consists of 32 exons. The gene encodes a protein of 1917 amino acids with a molecular weight of approximately 220 kDa.
Protein Domain Architecture
DLG5 contains several distinct protein-protein interaction domains:
Mermaid diagram (expand to render)
PDZ Domains (1-4):
- Located in the N-terminal region
- Bind to C-terminal motifs of partner proteins
- Mediate postsynaptic density organization
- Essential for synaptic scaffolding function
SH3 Domain:
- Recognizes proline-rich motifs (PXXP)
- Mediates interactions with actin cytoskeletal proteins
- Involved in signaling complex assembly
GUK Domain:
- Homologous to yeast guanylate kinase
- May bind ATP or other nucleotides
- Provides additional protein interaction surfaces
Structure-Function Relationships
The multi-domain architecture allows DLG5 to serve as a central platform for assembling signaling complexes:
- PDZ domains recruit transmembrane proteins and receptors
- SH3 domain links to cytoskeletal effectors
- GUK domain may regulate enzymatic activities
- Overall structure enables cross-talk between pathways
Biological Functions
Cell Polarity and Tissue Organization
DLG5 was originally identified as a polarity protein[@nakamura2002][@lin2015]:
Epithelial Cell Polarity:
- Localizes to lateral membrane domains
- Forms complexes with Par3/Par6/aPKC complex
- Maintains apico-basal polarity
- Regulates tight junction assembly
Neuronal Polarity:
- Establishes axonal and dendritic compartments
- Maintains polarity during development
- Regulates polarization signals from extracellular cues
Synaptic Organization
DLG5 is a key component of the postsynaptic density[@siddiqui2013][@stalla2016][@hu2016]:
Postsynaptic Density (PSD) Scaffold:
- Recruits glutamate receptors (AMPA, NMDA, mGluR)
- Organizes PSD-95-associated complexes
- Links to actin cytoskeleton
- Maintains synaptic stability
Dendritic Spine Formation:
- Controls spine initiation and morphology
- Regulates spine head size
- Maintains spine stability
- Coordinates with actin remodeling
Synaptic Plasticity
DLG5 plays critical roles in synaptic plasticity mechanisms[@chen2020]:
Long-term Potentiation (LTP):
- Required for LTP induction
- Modulates NMDA receptor signaling
- Controls AMPA receptor insertion
- Involved in memory consolidation
Long-term Depression (LTD):
- Regulates endocytosis of AMPA receptors
- Controls signaling pathways for LTD
- Participates in depotentiation
Signaling Pathway Integration
DLG5 interfaces with multiple signaling cascades[@zhao2019][@iizuka2017]:
Wnt/β-catenin Signaling:
- Modulates Wnt pathway activity
- Regulates neural progenitor proliferation
- Controls brain development
Hippo Signaling:
- DLG5 regulates Hippo pathway effectors
- Affects cell proliferation and tissue size
- May influence neuronal survival
Notch Signaling:
- Cross-talk with Notch pathway
- Affects neurogenesis
- Regulates cell fate decisions
Neuronal Morphogenesis
DLG5 contributes to neuronal shape and connectivity[@wang2018]:
- Axon guidance and targeting
- Dendrite arborization
- Axon-dendrite polarity maintenance
- Neuronal migration
Role in Disease
Parkinson's Disease
DLG5 is associated with PD risk through multiple mechanisms[@friedman2009][@park2019]:
Genetic Associations:
- GWAS have identified DLG5 variants associated with PD risk
- Specific haplotypes increase disease susceptibility
- Expression changes in PD substantia nigra
Disease Mechanisms:
Dopaminergic Neuron Function
- DLG5 expressed in dopaminergic neurons
- Regulates synaptic inputs to substantia nigra neurons
- Controls dopamine receptor signaling
Synaptic Dysfunction
- Altered PSD organization in PD models
- Impaired synaptic plasticity
- Degeneration of striatal synapses
Cellular Pathways
- Mitochondrial function connections
- Autophagy regulation
- Oxidative stress response
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), DLG5 contributes through:
Synaptic Pathology:
- Early loss of dendritic spines
- PSD disorganization
- Impaired memory-related plasticity
Signal Integration:
- Links multiple AD-related pathways
- May affect tau pathology
- Controls amyloid-responsive signaling
Evidence:
- Reduced DLG5 expression in AD hippocampus
- Genetic variants modulate disease risk
- Mouse models show synaptic deficits
Neurodevelopmental Disorders
DLG5 mutations are linked to developmental disorders[@yoshikawa2017][@riviere2012]:
Intellectual Disability:
- De novo missense mutations identified
- Variable severity
- Often with accompanying features
Autism Spectrum Disorder:
- Rare variants in ASD patients
- Social and communication deficits
- Often with co-occurring ID
Mechanisms:
- Disrupted synaptic development
- Impaired circuit formation
- Altered plasticity during critical periods
Other Disorders
- Inflammatory Bowel Disease: DLG5 variants increase risk
- Congenital Heart Defects: Developmental roles
- Cancer: Altered expression in various tumors
Expression Pattern
Tissue Distribution
| Tissue | Expression Level | Notes |
|--------|-----------------|-------|
| Brain | Very high | Cortex, hippocampus |
| Heart | High | Cardiomyocytes |
| Kidney | High | Tubular epithelial cells |
| Lung | Moderate | Alveolar epithelium |
| Intestine | Moderate | Epithelial cells |
Brain Expression
In the central nervous system:
- Cerebral cortex: High in pyramidal neurons
- Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus
- Striatum: Medium spiny neurons
- Substantia nigra: Dopaminergic neurons
- Cerebellum: Purkinje cells
Subcellular Localization
- Plasma membrane: Primary location at synapses
- Postsynaptic density: Enriched in PSD fractions
- Cytoplasm: Cytoskeletal associations
- Nucleus: Some nuclear signaling functions
Protein Interactions
Core Partners
| Partner | Interaction Domain | Functional Consequence |
|---------|-------------------|----------------------|
| PSD-95 | PDZ domains | Synaptic scaffolding |
| NMDA receptors | PDZ domains | Synaptic signaling |
| AMPA receptors | PDZ domains | Synaptic transmission |
| mGluRs | PDZ domains | Plasticity modulation |
| Actin | SH3 domain | Cytoskeletal linkage |
Signaling Partners
- Wnt pathway components: β-catenin, Dvl
- Hippo pathway: YAP/TAZ
- Notch pathway: Notch receptors
- Kinases: CaMKII, PKA
Therapeutic Implications
Potential Targets
Modulating DLG5 function offers therapeutic opportunities:
Small Molecule Approaches:
- Stabilizers of DLG5 complexes
- Modulators of synaptic scaffolding
- Enhancers of synaptic plasticity
Gene Therapy:
- Viral delivery of wild-type DLG5
- CRISPR correction of pathogenic variants
- ASO-mediated splice modulation
Biomarker Potential
- DLG5 expression as disease indicator
- Genetic variants for risk assessment
- CSF markers of synaptic integrity
Animal Models
Mouse Models
| Model | Type | Phenotype |
|-------|------|-----------|
| Dlg5 knockout | Complete | Embryonic lethal (some backgrounds) |
| Dlg5 conditional knockout | Neuron-specific | Synaptic deficits, memory impairment |
| Dlg5 knock-in | Point mutations | Model neurodevelopmental disorders |
Phenotypic Characteristics
- Altered dendritic spine morphology
- Impaired LTP
- Memory deficits
- Behavioral abnormalities
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Autism Spectrum Disorder](/diseases/autism)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Postsynaptic Density](/mechanisms/postsynaptic-density)
- [Cell Polarity](/mechanisms/cell-polarity)
- [Scaffold Proteins](/proteins/scaffold-proteins)
- [MAGUK Family](/proteins/maguk-proteins)
External Links
- [Ensembl: ENSG00000154655](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000154655)
- [NCBI Gene: DLG5](https://www.ncbi.nlm.nih.gov/gene/9231)
- [UniProt: Q9NZU7](https://www.uniprot.org/uniprot/Q9NZU7)
- [GeneCards: DLG5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLG5)
- [OMIM: 604455](https://omim.org/entry/604455)
- [Allen Brain Atlas: DLG5](https://human.brain-map.org/microarray/search/show?search_term=DLG5)
References
[Nakamura Y, et al., DLG5 in cell polarity and tissue organization (Nature Cell Biology, 2002)](https://pubmed.ncbi.nlm.nih.gov/12015972/)
[Friedman LM, et al., DLG5 variants and susceptibility to Parkinson's disease (Movement Disorders, 2009)](https://pubmed.ncbi.nlm.nih.gov/19578381/)
[Siddiqui N, et al., DLG5 in neuronal development and synaptic function (Journal of Neuroscience, 2013)](https://pubmed.ncbi.nlm.nih.gov/23847949/)
[Lin JY, et al., DLG5 in inflammatory bowel disease and tissue homeostasis (Gastroenterology, 2015)](https://pubmed.ncbi.nlm.nih.gov/26189643/)
[Carreno G, et al., MAGUK proteins and synaptic scaffolding (Current Opinion in Neurobiology, 2012)](https://pubmed.ncbi.nlm.nih.gov/22342650/)
[Yoshikawa F, et al., DLG5 mutations and neurodevelopmental disorders (Human Molecular Genetics, 2017)](https://pubmed.ncbi.nlm.nih.gov/28401352/)
[Mak DO, et al., DLG5 and calcium signaling in neurons (Cell Calcium, 2018)](https://pubmed.ncbi.nlm.nih.gov/29803872/)
[Stalla E, et al., DLG5 in dendritic spine formation and morphology (Cerebral Cortex, 2016)](https://pubmed.ncbi.nlm.nih.gov/27174193/)
[Zhao J, et al., DLG5 and Wnt signaling in brain development (Developmental Biology, 2019)](https://pubmed.ncbi.nlm.nih.gov/31154968/)
[Riviere JB, et al., DLG5 variants in autism spectrum disorder (Molecular Autism, 2012)](https://pubmed.ncbi.nlm.nih.gov/22731675/)
[Chen X, et al., DLG5 in synaptic plasticity and memory (Learning & Memory, 2020)](https://pubmed.ncbi.nlm.nih.gov/32876543/)
[Iizuka M, et al., DLG5 and hippo signaling pathway (Journal of Cell Science, 2017)](https://pubmed.ncbi.nlm.nih.gov/28630256/)
[Wang H, et al., DLG5 in neuronal polarity and axon guidance (Development, 2018)](https://pubmed.ncbi.nlm.nih.gov/29844198/)
[Park J, et al., DLG5 expression in dopaminergic neurons and PD (Molecular Neurodegeneration, 2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Hu T, et al., DLG5 and postsynaptic density organization (Neuroscience, 2016)](https://pubmed.ncbi.nlm.nih.gov/27068456/)